StockData
Elutia Inc. logo

Elutia Inc. (ELUT) stock

ELUTNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 10, 2026Score 9/3011% below fair value
$0.85+0.03 (+3.77%)

Close on Nov 17, 2026Market cap $37.82MP/E –Yield –

Elutia total assets

Total assets on the balance sheet at the end of each period.

Elutia's total assets was $43.65M at Jun 30, 2026. For fiscal 2025 it was $62.35M, up 72.6% from the year before. The highest annual figure on record is $82.81M in fiscal 2020.

Annual total assets

PeriodPeriod endValueChange
FY2025Dec 31, 2025$62.35M+72.6%
FY2024Dec 31, 2024$36.13M-16.8%
FY2023Dec 31, 2023$43.43M-36.9%
FY2022Dec 31, 2022$68.84M+2.5%
FY2021Dec 31, 2021$67.17M-18.9%
FY2020Dec 31, 2020$82.81M+85.0%
FY2019Dec 31, 2019$44.77M–

Quarterly total assets

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$43.65M+29.0%
Q1 FY2026Mar 31, 2026$55.21M+40.5%
Q4 FY2025Dec 31, 2025$62.35M+72.6%
Q3 FY2025Sep 30, 2025$29.41M-39.3%
Q2 FY2025Jun 30, 2025$33.85M-19.2%
Q1 FY2025Mar 31, 2025$39.30M+11.1%
Q4 FY2024Dec 31, 2024$36.13M-16.8%
Q3 FY2024Sep 30, 2024$48.41M-11.3%
Q2 FY2024Jun 30, 2024$41.90M-19.9%
Q1 FY2024Mar 31, 2024$35.36M-41.7%
Q4 FY2023Dec 31, 2023$43.43M-36.9%
Q3 FY2023Sep 30, 2023$54.58M+3.3%
Q2 FY2023Jun 30, 2023$52.33M-12.7%
Q1 FY2023Mar 31, 2023$60.63M-9.7%
Q4 FY2022Dec 31, 2022$68.84M+14.9%
Q2 FY2022Jun 30, 2022$52.85M-24.2%
Q1 FY2022Mar 31, 2022$59.93M-19.2%
Q4 FY2021Dec 31, 2021$67.17M-18.9%
Q3 FY2021Sep 30, 2021$59.90M+29.8%
Q2 FY2021Jun 30, 2021$69.70M+55.7%
Q1 FY2021Mar 31, 2021$74.21M–
Q4 FY2020Dec 31, 2020$82.81M–
Q3 FY2020Sep 30, 2020$46.14M–
Q4 FY2019Dec 31, 2019$44.77M–

More Elutia figures

See a number that looks wrong?